Antibiotic prophylaxis for chronic obstructive pulmonary disease: Resurrecting an old idea

American Journal of Respiratory and Critical Care Medicine

Volumn 178, Issue 11, 2008, Pages 1098-1099

  Kunisaki, Ken M ^a   Niewoehner, Dennis E ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; AZITHROMYCIN; CIGARETTE SMOKE; CORTICOSTEROID; ERYTHROMYCIN; GAMMA1B INTERFERON; MACROLIDE; PLACEBO;

ALLERGIC REACTION; ANTIBIOTIC PROPHYLAXIS; BRONCHIOLITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; DISEASE EXACERBATION; DOSE RESPONSE; DRUG MECHANISM; EDITORIAL; FIBROSING ALVEOLITIS; GASTROINTESTINAL DISEASE; HOSPITALIZATION; HUMAN; LIVER DYSFUNCTION; LUNG FIBROSIS; LUNG FUNCTION; OTOTOXICITY; PRIORITY JOURNAL; QT PROLONGATION;

ANTIBIOTIC PROPHYLAXIS; DRUG RESISTANCE, BACTERIAL; ERYTHROMYCIN; HUMANS; MACROLIDES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 56749154079     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.200808-1315ED     Document Type: Editorial

References (16)

1. Fletcher CM. Chronic bronchitis: its prevalence, nature and pathogenesis. Am Rev Respir Dis 1959;80:483-494.
2. Black P, Staykova T, Chacko E, Ram FS, Poole P. Prophylactic antibiotic therapy for chronic bronchitis. Cochrane Database Syst Rev 2003;1:CD004105.
3. Fletcher CM, Oldham PD. Value of chemoprophylaxis and chemotherapy in early chronic bronchitis: a report to the Medical Research Council by their Working Party on Trials of Chemotherapy in Early Chronic Bronchitis. BMJ 1966;1:1317-1322.
4. Johnston RN, McNeill RS, Smith DH, Dempster MB, Nairn JR, Purvis MS, Watson JM, Ward FG. Five-year winter chemoprophylaxis for chronic bronchitis. BMJ 1969;4:265-269.
5. Kudoh S, Uetake T, Hagiwara K, Hirayama M, Hus LH, Kimura H, Sugiyama Y. Clinical effects of low-dose long-term erythromycin chemotherapy on diffuse panbronchiolitis. Nihon Kyobu Shikkan Gakkai Zasshi 1987;25:632-642.
6. Nagai H, Shishido H, Yoneda R, Yamaguchi E, Tamura A, Kurashima A. Long-term low-dose administration of erythromycin to patients with diffuse panbronchiolitis. Respiration 1991;58:145-149.
7. Koyama H, Geddes D. Erythromycin and diffuse panbronchiolitis. Thorax 1997;52:915-918.
8. Shinkai M, Henke MO, Rubin BK. Macrolide antibiotics as immunomodulatory medications: proposed mechanisms of action. Pharmacol Ther 2008;117:393-405.
9. Hoiby N. Diffuse panbronchiolitis and cystic fibrosis: East meets West. Thorax 1994;49:531-532.
10. Southern KW, Barker PM, Solis A. Macrolide antibiotics for cystic fibrosis. Cochrane Database Syst Rev 2004; (2):CD002203.
11. Clement A, Tamalet A, Leroux E, Ravilly S, Fauroux B, Jais J. Long term effects of azithromycin in patients with cystic fibrosis: a double blind, placebo controlled trial. Thorax 2006;61:895-902.
12. Seemungal TAR, Wilkinson TMA, Hurst JR, Perera WR, Sapsford RJ, Wedzicha JA. Long-term erythromycin therapy is associated with decreased chronic obstructive pulmonary disease exacerbations. Am J Respir Crit Care Med 2008;11:1139-1147.
13. Shaffer D, Singer S, Kervick J, Honig P. Concomitant risk factors in reports of torsades de pointes associated with macrolide use: review of the United States Food and Drug Administration Adverse Event Reporting System. Clin Infect Dis 2002;35:197-200.
14. Raghu G, Brown KK, Bradford WZ, Starko K, Noble PW, Schwartz DA, King TE Jr.; the Idiopathic Pulmonary Fibrosis Study Group. A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis. N Engl J Med 2004;350:125-133.
15. Halbert RJ, Natoli JL, Gano A, Badamgarav E, Buist AS, Mannino DM. Global burden of COPD: systematic review and meta-analysis. Eur Respir J 2006;28:523-532.
16. Malhotra-Kumar S, Lammens C, Coenen S, Van Herck K, Goosens H. Effect of azithromycin and clarithromycin therapy on pharyngeal carriage of macrolide-resistant streptococci in healthy volunteers: a randomised, double-blind, placebo-controlled study. Lancet 2007;369:482-490.